Answers - Finance

The rise of venture leasing and lending has created an opportunity for sophisticated entrepreneurs to gain a competitive advantage. Savvy entrepreneurs are using venture leases and loans to generate millions of dollars for shareholders by leveraging existing venture capi

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

tal. They have discovered ways to use this flexible financing as a tool to build enterprise value between equity rounds and to leapfrog less sophisticated competitors.

Venture leases and loans are usually asset-based, financing arrangements. These financings are availab

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

e to qualified pre-profit, early-stage companies funded by venture capital investors. Start-ups need equipment and working capital to help them execute their business plans and to reach profitability. Venture lenders and lessors provide financing to these firms to help t

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

hem acquire computers, lab and test equipment, production equipment, phone systems and other needed business equipment.

These specialty financing firms may also provide financing for working capital in the form of accounts receivable and/or inventory loans. Start-ups th

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

t qualify usually have promising business prospects, well-defined business plans and have raised more than $ 5 million in venture capital from reputable venture capitalists.

How are these savvy entrepreneurs using venture leases and loans to boost shareholder value and

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

o gain an edge on the competition? Here are some of the ways:

1. To stretch equity capital and to increase shareholder value between equity rounds. By using venture leases and loans, entrepreneurs can forestall going out for more equity while they continue to build and

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

increase the value of their companies.

2. Use of loans and leases instead of internal cash helps to stem negative cash flow. Most start-ups are faced with negative cash flow until revenues build sufficiently to cover costs. Using limited internal cash for equipment pur

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

hases, to invest in inventory or for accounts receivable is not wise, if there are better options.

3. To protect working capital. Purchases of intermediate-term assets with internal cash will remove those funds from working capital. Use of venture leases and loans helps

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

to keep the pressure off of working capital as the cost of these assets gets spread over an extended period.

4. To supplement other capital sources. Venture leases and loans supplement equity capital, mortgage financing and other financing available to start-ups.

5. T

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

liberate cash from equipment, accounts receivable and inventory already financed internally. By doing a sale-leaseback, the start-up can liberate cash from equipment already owned. Likewise, the start-up can finance inventory and accounts receivable that have been funde

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

internally by using a venture loan.

6. To bridge-finance equity transactions. Occasionally, start-ups are able to obtain short-term loans to bridge upcoming equity transactions. These loans are usually well secured by all-asset liens against these companies and are gen

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

erally available for short time frames. Most venture lenders who provide this type of financing require equity kickers in the form of warrants to purchase stock in the start-ups or stock issued directly to them by the start-ups.

7. To hedge against rapidly depreciating

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

quipment. Venture leases can be structured as fair-market-value leases. These leases usually allow the lessees to renew the leases at fair-market-value renewal rates, to purchase the equipment at fair-market-value purchase prices, or to return the equipment to the lessor

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

s at the end of the leases. The return option allows the start-ups to conveniently dispose of obsolete or unneeded equipment.

8. To replace venture capital. Start-ups are using loans in the form of subordinate debt as a substitute for additional equity rounds. These loa

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

s can be collateralized or unsecured and can be used for many of the same purposes as equity funding – to continue product development, to add key personnel, to expand marketing and to support sales efforts. Venture lenders generally charge a premium rate for these loans

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

and require sizeable equity kickers in the form of warrants or ownership shares in the start-ups. These loans are generally cheaper than equity financing and may amortize faster.

9. To spread equipment cost over the productive life of the equipment. By being able to spr

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

ead the cost of the equipment over an extended period, start-ups can get productivity out of these assets while they pay. Paying for the assets out of internal cash has just the opposite effect.

10. To quickly build out infrastructure to allow all employees to be more p

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

oductive sooner. Venture leasing and lending allow start-ups to add computers, phone systems, networking equipment, software and other business essentials quickly. Employees can be more productive sooner and benchmarks can be reached faster.

Using venture leases and loa

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ns is a smart choice for savvy entrepreneurs. It allows them to build substantial equity value with minimal dilution. These arrangements usually do not require board representation or loss of management control. Start-ups are able to add needed equipment and finance work

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ng capital with lots of flexibility. Additionally, these forms of financing are significantly cheaper than the likely alternative, more venture capital financing. Savvy entrepreneurs have discovered these advantages and are using them to put their firms ahead of the pack

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/104822/answers-Ten-Ways-Startups-Use-Venture-Leases-And-Loans-To-Generate-Millions.html">Ten Ways Start-ups Use Venture Leases And Loans To Generate Millions</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/104822/answers-Ten-Ways-Startups-Use-Venture-Leases-And-Loans-To-Generate-Millions.html]Ten Ways Start-ups Use Venture Leases And Loans To Generate Millions[/url]

Moments of truth are all those times when customers experience and evaluate your service. Work hard, do a good job, and customers will come back for more.

A focus group is a group of employees or current customers that discuss and brainstorm new ways to improve different parts of your business. Below are online promotion secrets to use focus groups for marketing intelligence.

Online mode of dealings have since long captured every other aspect of life. Let that be ordering groceries for daily use or purchasing machinery equipment for a large sized plant, all can be done with just a few clicks. If the varied offerings and endless variety is present on a screen in front, who is interested in spending time and / or monetary resources in undertaking the search and making purchase?

Tags

Links

Answers - Ten Ways Start-ups Use Venture Leases And Loans To Generate Millions

Related Articles: